Brain Health in Breast Cancer Survivors
Recruiting
Observational Study
Cognitive Impairment
Cognitive Function
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 35 – 65
- Sex
- Female
- Study type
- Observational
- Participants needed
- 120 (estimated)
- Sponsor
- Jonsson Comprehensive Cancer Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Endocrine therapy (ET) is widely used to treat hormone receptor positive breast cancer and prevent recurrence by downregulating estrogen function. However, ETs readily cross the blood brain barrier and interfere with the action of estrogen in the brain. Estrogen supports cognition and menopausal status is closely linked to cognitive health in women. This has raised concern that anti-estrogen ETs m…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 35-65
* Fluent in English
* Adequate vision/hearing to complete testing
Exclusion Criteria:
* History of major or mild neurocognitive disorder or dementia
* Diagnosis of major neurological condition (e.g., epilepsy, Parkinson's Disease, stroke)
* Diagnosis of a major psy…
Contacts